Marksans Pharma informs about press release

17 Nov 2025 Evaluate
Marksans Pharma has informed that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its following products from UK MHRA: 1. Mefenamic Acid 250 mg Film-Coated Tablets, 2. Mefenamic Acid 500 mg Film-Coated Tablets.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×